146 related articles for article (PubMed ID: 30944615)
1. Natural killer cell monitoring in cutaneous melanoma - new dynamic biomarker.
Isvoranu G; Surcel M; Huică RI; Munteanu AN; Pîrvu IR; Ciotaru D; Constantin C; Bratu O; Neagu M; Ursaciuc C
Oncol Lett; 2019 May; 17(5):4197-4206. PubMed ID: 30944615
[TBL] [Abstract][Full Text] [Related]
2. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells.
Terao H; Harada M; Kurosawa S; Shinomiya Y; Ito O; Tamada K; Takenoyama M; Nomoto K
Immunobiology; 1996 Jul; 195(2):172-86. PubMed ID: 8877394
[TBL] [Abstract][Full Text] [Related]
3. Notch1 signaling in melanoma cells promoted tumor-induced immunosuppression via upregulation of TGF-β1.
Yang Z; Qi Y; Lai N; Zhang J; Chen Z; Liu M; Zhang W; Luo R; Kang S
J Exp Clin Cancer Res; 2018 Jan; 37(1):1. PubMed ID: 29301578
[TBL] [Abstract][Full Text] [Related]
4. Natural killer receptors on CD8 T cells and natural killer cells from different HLA-C phenotypes in melanoma patients.
Campillo JA; Martínez-Escribano JA; Moya-Quiles MR; Marín LA; Muro M; Guerra N; Parrado A; Campos M; Frías JF; Minguela A; García-Alonso AM; Alvarez-López MR
Clin Cancer Res; 2006 Aug; 12(16):4822-31. PubMed ID: 16914567
[TBL] [Abstract][Full Text] [Related]
5. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
Markovic SN; Murasko DM
Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
[TBL] [Abstract][Full Text] [Related]
6. [Effects of excreted/secreted antigens of Toxoplasma gondii on CD4+ CD25+ Foxp3+ T cells and NK cells of melanoma-bearing mice].
Jiao YM; Zhang L; Ge YY; Liang YJ; Yong W
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):301-6. PubMed ID: 22164498
[TBL] [Abstract][Full Text] [Related]
7. Effect of human natural killer and gammadelta T cells on the growth of human autologous melanoma xenografts in SCID mice.
Lozupone F; Pende D; Burgio VL; Castelli C; Spada M; Venditti M; Luciani F; Lugini L; Federici C; Ramoni C; Rivoltini L; Parmiani G; Belardelli F; Rivera P; Marcenaro S; Moretta L; Fais S
Cancer Res; 2004 Jan; 64(1):378-85. PubMed ID: 14729648
[TBL] [Abstract][Full Text] [Related]
8. The modulation of B16BL6 melanoma metastasis is not directly mediated by cytolytic activity of natural killer cells in alcohol-consuming mice.
Spitzer JH; Núñez NP; Meadows SA; Gallucci RM; Blank SE; Meadows GG
Alcohol Clin Exp Res; 2000 Jun; 24(6):837-44. PubMed ID: 10888072
[TBL] [Abstract][Full Text] [Related]
9. Murine B16 melanoma vaccination-induced tumor immunity: identification of specific immune cells and functions involved.
Wu TY; Fleischmann WR
J Interferon Cytokine Res; 2001 Dec; 21(12):1117-27. PubMed ID: 11798470
[TBL] [Abstract][Full Text] [Related]
10. The Effects of Mesenchymal Stem Cells on Antimelanoma Immunity Depend on the Timing of Their Administration.
Miloradovic D; Miloradovic D; Markovic BS; Acovic A; Harrell CR; Djonov V; Arsenijevic N; Volarevic V
Stem Cells Int; 2020; 2020():8842659. PubMed ID: 32695181
[TBL] [Abstract][Full Text] [Related]
11. Early-appearing tumour-infiltrating natural killer cells play a crucial role in the generation of anti-tumour T lymphocytes.
Kurosawa S; Harada M; Matsuzaki G; Shinomiya Y; Terao H; Kobayashi N; Nomoto K
Immunology; 1995 Jun; 85(2):338-46. PubMed ID: 7642226
[TBL] [Abstract][Full Text] [Related]
12. NK and CD4 cells collaborate to protect against melanoma tumor formation in the brain.
Prins RM; Vo DD; Khan-Farooqi H; Yang MY; Soto H; Economou JS; Liau LM; Ribas A
J Immunol; 2006 Dec; 177(12):8448-55. PubMed ID: 17142742
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine Inhibition of Breast Tumor Growth Is B Cell Dependent and Associated With an Enhanced Antitumor Antibody Response.
Rogers D; Vila-Leahey A; Pessôa AC; Oldford S; Marignani PA; Marshall JS
Front Immunol; 2018; 9():1894. PubMed ID: 30158936
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
15. Myeloid expression of adenosine A2A receptor suppresses T and NK cell responses in the solid tumor microenvironment.
Cekic C; Day YJ; Sag D; Linden J
Cancer Res; 2014 Dec; 74(24):7250-9. PubMed ID: 25377469
[TBL] [Abstract][Full Text] [Related]
16. Innovative breakthroughs facilitated by single-cell multi-omics: manipulating natural killer cell functionality correlates with a novel subcategory of melanoma cells.
Zhao Z; Ding Y; Tran LJ; Chai G; Lin L
Front Immunol; 2023; 14():1196892. PubMed ID: 37435067
[TBL] [Abstract][Full Text] [Related]
17. NK and CD8+ T cell-mediated eradication of poorly immunogenic B16-F10 melanoma by the combined action of IL-12 gene therapy and 4-1BB costimulation.
Xu D; Gu P; Pan PY; Li Q; Sato AI; Chen SH
Int J Cancer; 2004 Apr; 109(4):499-506. PubMed ID: 14991570
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of tumor infiltrating lymphocyte clones derived from B16-F10 murine melanoma.
Maeda K; Lafreniere R; Jerry LM
J Invest Dermatol; 1991 Aug; 97(2):183-9. PubMed ID: 2071934
[TBL] [Abstract][Full Text] [Related]
19. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
20. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]